Published Scientific Articles
Download the manuscript: Tyrosine Phosphorylation of p27Kip1 Correlates with Palbociclib Responsiveness in Breast Cancer Tumor Cells Grown in Explant Culture
Download Stacy’s article: Targeting p27 tyrosine phosphorylation as a modality to inhibit CDK4 and CDK2 and cause cell cycle arrest in breast cancer cells.
Download Stacy and Priyank’s article:
Dual Inhibition of CDK4 and CDK2 via Targeting p27 Tyrosine Phosphorylation Induces a Potent and Durable Response in Breast Cancer Cells
Awards and Prizes
Concarlo in the News
Read the Drug Discovery World article about Concarlo, also featured in their fall issue.
Click to read the BioCentury Emerging Company Profile.
Click to read the Life Science Newswire press release.
Features Dr. Stacy Blain, Co-Founder and Chief Scientific Officer, Concarlo Holdings
SUNY Downstate Startup Company Secures Over $1 Million in Seed Funding Investment for Advancement of Proprietary Cancer Companion Diagnostic Test
Increasing diversity in the science technology engineering & mathematics (STEM) workforce.
Research Associate Sarah Teed, M.S. welcomes young students to learn more about Concarlo’s mission.
Webinars and Talks
Watch our webinar to learn about an opportunity to join the fight against metastatic breast cancer.
Join this webinar to hear from Concarlo’s CEO and CSO Dr. Stacy Blain and COO LisaMarie Casey as they discuss the science behind a remarkable breakthrough in the treatment of metastatic cancers.
Watch our webinar to learn about the incredible progress that’s being made to achieve these goals and what is still on the horizon.
Stacy was a panelist at Princeton Entrepreneurship Council’s popular panel discussion series. Click to learn more.
Stacy Blain was a panelist at Columbia University’s Social Enterprise Conference.
Stacy Blain was a panelist at WE NYC’s annual summit, Female Founders Disrupting HealthTech, at the New York Genome Center.